Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-01-25, Stock:LLY, The news for the past five days is as follows:
2021-01-15: NEWS1: Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement.NEWS2: Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals.NEWS3: Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund.
2021-01-19: NEWS1: Lilly Awash In Catalysts, Pipeline Updates, Mizuho Says In Upgrade.NEWS2: Eli Lilly Stock Is Still Pricey. Why It Might Be a Buy..NEWS3: Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies.
2021-01-20: NEWS1: Eli Lilly Stock Is Surging on Hope for Alzheimer’s Drug. Analyst Says It Won’t Last..NEWS2: Precision BioSciences' (DTIL) New Lymphoma Drug IND Gets FDA Nod.NEWS3: Lilly signs cancer drug deal worth up to $1.6 billion.NEWS4: The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study.NEWS5: Lilly (LLY) Inks Deal With Merus to Discover Cancer Antibodies.
2021-01-21: NEWS1: Coronavirus update: Biden signs more COVID-19 orders; Pfizer wants to expand sales to states.NEWS2: Eli Lilly's Antibody Reduces COVID-19 Risk by 80% in Nursing Homes.NEWS3: Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 per cent for residents.NEWS4: Jim Cramer on Amazon, Eli Lilly, FuelCell, Vaccines, Stock Market Thursday.NEWS5: LIVE: Jim Cramer on Amazon, Eli Lilly, FuelCell, FAANG, Stock Market Thursday.NEWS6: Eli Lilly Says Covid-19 Treatment Reduces Risk for Nursing Home Residents.NEWS7: Eli Lilly Says Its Antibody Prevented Covid-19 in Nursing Home Residents.NEWS8: Lilly says antibody drug cuts COVID-19 risk for nursing home residents.NEWS9: Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 percent for residents.
2021-01-22: NEWS1: Lilly's (LLY) Bamlanivimab Lowers COVID-19 Risk in Nursing Homes.NEWS2: Lilly Completes Acquisition of Prevail Therapeutics.NEWS3: Pharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLY's New Antibody Deal.NEWS4: The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa.

Answer: Rise